Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steato hepatitis have an increasing prevalence among liver diseases. Overweight and obesity are frequently associated conditions in patients with fatty liver. Skeletal muscle mass depletion may also coexist with chronic liver disease even in obese patients. This review will focus on the relationship between sarcopenic obesity and fatty liver
Sarcopenia, defined as the loss of muscle strength, mass, and functionality, confers a poor prognosi...
Non-alcoholic fatty liver disease (NAFLD) has reached epidemic proportions, affecting an estimated o...
Background/aims: Sarcopenia is associated with liver fibrosis in patients with nonalcoholic fatty li...
International audienceAn extensive body of the literature shows a strong interrelationship between t...
: Sarcopenia is increasingly recognized in patients with nonalcoholic liver disease (NAFLD). Initial...
Sarcopenia is associated with nonalcoholic fatty liver disease (NAFLD). This study investigated whet...
: Sarcopenia is increasingly recognised in patients with non-alcoholic liver disease (NAFLD). Initia...
none8noBackground: Sarcopenia recognises insulin resistance and obesity as risk factors, and is freq...
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver disease worldwide. Obesity is a...
Although sarcopenia is known to be a risk factor for non-alcoholic fatty liver disease (NAFLD), whet...
Accumulating evidence supports a connection between sarcopenic obesity (SO) and NAFLD. The extent to...
A relationship between nonalcoholic fatty liver disease (NAFLD) and sarcopenia has been suggested. T...
The link between metabolic syndrome (MetS) and sarcopenia has not been extensively studied, but it i...
Takashi Shida,1 Natsumi Oshida,2 Sechang Oh,3 Kosuke Okada,1 Junichi Shoda41Tsukuba Preventive Medic...
Background: Retrospective cross‐sectional studies link sarcopenia and myosteatosis with non‐alcoholi...
Sarcopenia, defined as the loss of muscle strength, mass, and functionality, confers a poor prognosi...
Non-alcoholic fatty liver disease (NAFLD) has reached epidemic proportions, affecting an estimated o...
Background/aims: Sarcopenia is associated with liver fibrosis in patients with nonalcoholic fatty li...
International audienceAn extensive body of the literature shows a strong interrelationship between t...
: Sarcopenia is increasingly recognized in patients with nonalcoholic liver disease (NAFLD). Initial...
Sarcopenia is associated with nonalcoholic fatty liver disease (NAFLD). This study investigated whet...
: Sarcopenia is increasingly recognised in patients with non-alcoholic liver disease (NAFLD). Initia...
none8noBackground: Sarcopenia recognises insulin resistance and obesity as risk factors, and is freq...
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver disease worldwide. Obesity is a...
Although sarcopenia is known to be a risk factor for non-alcoholic fatty liver disease (NAFLD), whet...
Accumulating evidence supports a connection between sarcopenic obesity (SO) and NAFLD. The extent to...
A relationship between nonalcoholic fatty liver disease (NAFLD) and sarcopenia has been suggested. T...
The link between metabolic syndrome (MetS) and sarcopenia has not been extensively studied, but it i...
Takashi Shida,1 Natsumi Oshida,2 Sechang Oh,3 Kosuke Okada,1 Junichi Shoda41Tsukuba Preventive Medic...
Background: Retrospective cross‐sectional studies link sarcopenia and myosteatosis with non‐alcoholi...
Sarcopenia, defined as the loss of muscle strength, mass, and functionality, confers a poor prognosi...
Non-alcoholic fatty liver disease (NAFLD) has reached epidemic proportions, affecting an estimated o...
Background/aims: Sarcopenia is associated with liver fibrosis in patients with nonalcoholic fatty li...